Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
NCT02966860 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2017-04-05
Summary
A single-dose study evaluating the oral PK of an oxycodone/apap solution in healthy subjects under fasted conditions
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
Oral solution OC/APAP
Sponsors & Collaborators
-
Mallinckrodt
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2016-09-30
- Completion
- 2016-11-30
Countries
- United States
Study Locations
More Related Trials
-
Oxycodone Concentration in the Blood After Oral Premedication
NCT03386318 ·Status: COMPLETED
-
A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling
NCT07223450 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial
NCT02152592 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients
NCT01160614 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions
NCT00994942 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
NCT00226421 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
NCT00626600 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children
NCT04681027 ·Status: SUSPENDED ·Phase: PHASE3
-
Opioid Analgesia for MAB
NCT03139240 ·Status: COMPLETED ·Phase: PHASE4
-
Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain
NCT00911287 ·Status: COMPLETED ·Phase: PHASE3
-
Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone
NCT01456507 ·Status: COMPLETED ·Phase: PHASE1
-
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ·Status: ACTIVE_NOT_RECRUITING
-
A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions
NCT00864526 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
NCT00945919 ·Status: UNKNOWN ·Phase: NA
-
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NCT00911261 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers
NCT02750748 ·Status: COMPLETED ·Phase: PHASE1
-
Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction
NCT03105518 ·Status: UNKNOWN ·Phase: PHASE4
-
4-methylpyrazole and Acetaminophen Metabolism
NCT03878693 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin
NCT05929339 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics Study of ALO-02 and OxyContin
NCT01557257 ·Status: COMPLETED ·Phase: PHASE1
-
Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
NCT05962294 ·Status: UNKNOWN
-
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
NCT00765856 ·Status: TERMINATED ·Phase: PHASE3
-
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
NCT01428583 ·Status: COMPLETED ·Phase: PHASE3